Scarica l'app Stockscreener
24.07
4.26%
-1.07
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$25.14
Aprire:
$24.59
Volume 24 ore:
421.42K
Relative Volume:
1.05
Capitalizzazione di mercato:
$1.15B
Reddito:
$151.91M
Utile/perdita netta:
$-46.03M
Rapporto P/E:
-23.83
EPS:
-1.01
Flusso di cassa netto:
$5.65M
1 W Prestazione:
-7.17%
1M Prestazione:
-12.98%
6M Prestazione:
+9.16%
1 anno Prestazione:
+11.18%
Intervallo 1D:
$23.96
$24.73
Intervallo di 1 settimana:
$23.96
$26.68
Portata 52W:
$19.10
$29.62
Biolife Solutions Inc Stock (BLFS) Company Profile
Nome
Biolife Solutions Inc
Settore
Industria
Telefono
(425) 401-1400
Indirizzo
3303 MONTE VILLA PARKWAY, BOTHELL, WA
Confronta BLFS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLFS
Biolife Solutions Inc
|
24.07 | 1.21B | 151.91M | -46.03M | 5.65M | -1.01 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Biolife Solutions Inc Stock (BLFS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-22 | Ripresa | Stephens | Overweight |
| 2024-09-30 | Iniziato | H.C. Wainwright | Buy |
| 2024-04-04 | Iniziato | Jefferies | Buy |
| 2023-07-11 | Iniziato | Craig Hallum | Buy |
| 2022-04-25 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-10-19 | Iniziato | B. Riley Securities | Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-05-14 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-03-23 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2020-11-10 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2020-09-22 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-09-18 | Iniziato | Cowen | Outperform |
| 2020-08-11 | Downgrade | The Benchmark Company | Buy → Hold |
| 2020-07-08 | Reiterato | Maxim Group | Buy |
| 2020-02-24 | Iniziato | Lake Street | Buy |
| 2020-02-19 | Iniziato | The Benchmark Company | Buy |
| 2020-02-06 | Ripresa | B. Riley FBR | Buy |
| 2020-01-08 | Iniziato | Stephens | Overweight |
| 2019-11-21 | Iniziato | Oppenheimer | Outperform |
| 2019-07-22 | Iniziato | H.C. Wainwright | Buy |
| 2017-11-10 | Reiterato | Maxim Group | Buy |
| 2017-09-19 | Reiterato | Maxim Group | Buy |
| 2017-07-05 | Aggiornamento | Janney | Neutral → Buy |
| 2017-03-10 | Reiterato | Maxim Group | Buy |
| 2017-01-19 | Iniziato | Maxim Group | Buy |
Mostra tutto
Biolife Solutions Inc Borsa (BLFS) Ultime notizie
How BioLife Solutions Inc. (BJX1) stock performs in volatility spikesEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Why BioLife Solutions Inc. (BJX1) stock stays on top picksPortfolio Update Summary & Short-Term Trading Alerts - newser.com
How BioLife Solutions Inc. stock trades during market volatilityJuly 2025 Volume & Community Verified Trade Signals - newser.com
Is BioLife Solutions Inc. (BJX1) stock attractive for growth fundsJuly 2025 Earnings & Daily Stock Trend Reports - newser.com
Will BioLife Solutions Inc. (BJX1) stock issue positive guidanceEarnings Growth Report & Safe Entry Zone Identification - newser.com
Visualizing BioLife Solutions Inc. stock with heatmapsTrend Reversal & Safe Investment Capital Preservation Plans - newser.com
BioLife Solutions CEO Makes a Major Stock Move - TipRanks
Insider Sell: Greef De Sells 100,000 Shares of BioLife Solutions Inc (BLFS) - GuruFocus
Biolife Solutions Insider Sold Shares Worth $2,580,422, According to a Recent SEC Filing - MarketScreener
Will BioLife Solutions Inc. outperform the marketTrade Signal Summary & High Accuracy Trade Alerts - newser.com
How institutional buying supports BioLife Solutions Inc. stockJuly 2025 Highlights & Entry Point Confirmation Signals - newser.com
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX), BioLife Solutions (BLFS) and Cardiff Oncology (CRDF) - The Globe and Mail
Published on: 2025-11-12 09:13:42 - newser.com
BioLife Solutions raises 2025 revenue guidance to $96M as cell processing momentum accelerates - MSN
Does BioLife Solutions Inc. qualify in momentum factor screeningTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
What to do if you’re stuck in BioLife Solutions Inc.Fed Meeting & Advanced Technical Analysis Signals - newser.com
BioLife Solutions (BLFS) Refocuses on Cell Processing After Evo Sale—Is Its Core Platform Ready to Scale? - simplywall.st
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2025 Earnings Call Transcript - Insider Monkey
Why BioLife Solutions (BLFS) Is Up After Raising 2025 Guidance and Sharpening Its Cell Processing Focus - Yahoo Finance
BioLife Solutions, Inc. (BLFS) Surpasses Q3 Earnings and Revenue Estimates - MSN
BioLife Solutions Reports Strong Q3 Earnings Growth - TipRanks
Using R and stats models for BioLife Solutions Inc. forecastingJuly 2025 Snapshot & Entry and Exit Point Strategies - newser.com
Will BioLife Solutions Inc. (BJX1) stock maintain strong growthOil Prices & Reliable Entry Point Trade Alerts - newser.com
BioLife Solutions Inc (BLFS) Q3 2025 Earnings Call Highlights: S - GuruFocus
BioLife Solutions Doubles Down On Cell Processing Profits - Finimize
Biolife Solutions Inc Azioni (BLFS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.23%
0.58%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):